| Firm | Analyst |
|---|---|
|
Chardan
|
Keay Nakae |
|
Guggenheim Securities
|
Debjit Chattopadhyay, Ph.D. |
|
H.C. Wainwright
|
Andrew Fein |
|
J.P. Morgan
|
Tessa Romero |
|
Jefferies
|
Andrew Tsai |
|
Morgan Stanley
|
Michael Ulz |
|
Oppenheimer
|
Francois Brisebois |
|
Piper Sandler
|
Edward Tenthoff |
|
Raymond James & Associates
|
Steven Seedhouse, Ph.D. |
|
RBC Capital Markets
|
Luca Issi |
|
Stifel
|
Paul Matteis |
Dyne Therapeutics, Inc. is followed by the analysts listed. Please note that any opinions, estimates or forecasts regarding Dyne Therapeutics, Inc.'s performance made by these analysts are theirs alone and do not represent opinions, forecasts or predictions of Dyne Therapeutics, Inc. or its management. Dyne Therapeutics, Inc. does not by its reference or distribution imply its endorsement of or concurrence with such information, conclusions or recommendations.
